Citation Impact
Citing Papers
Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells
2008 StandoutScienceNobel
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
2010
Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations
2013
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Oncogenesis Caused by Loss of the SNF5 Tumor Suppressor Is Dependent on Activity of BRG1, the ATPase of the SWI/SNF Chromatin Remodeling Complex
2009
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL
2010 StandoutNobel
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia
2010
Core Transcriptional Regulatory Circuit Controlled by the TAL1 Complex in Human T Cell Acute Lymphoblastic Leukemia
2012
Cancer statistics, 2020
2020 Standout
Cancer Statistics, 2021
2021 Standout
Technology platforms for pharmacogenomic diagnostic assays
2004
The RNA Binding Protein Quaking Regulates Formation of circRNAs
2015 Standout
Recent Advances in Plant Transformation
2010
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
2009
Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells
2015
Acute lymphoblastic leukaemia
2008
Brown and beige fat: development, function and therapeutic potential
2013 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
The tumor microenvironment is a dominant force in multidrug resistance
2012
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
2013
TGFβ signalling in context
2012 Standout
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
2005 StandoutNature
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
SWI/SNF nucleosome remodellers and cancer
2011 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Genotoxicity of Retroviral Integration In Hematopoietic Cells
2006
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
2010 StandoutNobel
Radiogenomic Analysis to Identify Imaging Phenotypes Associated with Drug Response Gene Expression Programs in Hepatocellular Carcinoma
2007
Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status
2007
Relapsed childhood acute lymphoblastic leukaemia
2013
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Environment-mediated drug resistance: a major contributor to minimal residual disease
2009
MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
2012
Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter snp that alters PARP1 binding and SMARCB1 expression
2007
Regulation of cancer cell metabolism
2011 Standout
Crohn's disease
2016 Standout
Purity for clarity: the need for purification of tumor cells in DNA microarray studies
2005
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
2013
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Phase transitions in the assembly of multivalent signalling proteins
2012 StandoutNature
Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor
2016
Clinical significance of early T‐cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children’s Cancer Study Group Study L99‐15
2011
Meeting the Global Food Demand of the Future by Engineering Crop Photosynthesis and Yield Potential
2015 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
The cancer stem cell: premises, promises and challenges
2011 Standout
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
2014
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci
2008
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies Parp1 as a Mediator of Olaparib Toxicity
2013
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
The PI3K Pathway in Human Disease
2017 Standout
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
2008
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
2013 Standout
Adipose Mitochondrial Biogenesis Is Suppressed in db/db and High-Fat Diet–Fed Mice and Improved by Rosiglitazone
2007
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal
2017
Hijacking the Chromatin Remodeling Machinery: Impact ofSWI/SNFPerturbations in Cancer
2009
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition
2010
Acute Myeloid Leukemia
2015 Standout
Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease
2016
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
2008 StandoutScienceNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL −/− clear cell renal carcinoma
2017 StandoutNobel
Arf tumor suppressor promoter monitors latent oncogenic signals in vivo
2003
Molecular Pathways: SWI/SNF (BAF) Complexes Are Frequently Mutated in Cancer—Mechanisms and Potential Therapeutic Insights
2013
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Outcome for children and young people with E arly T ‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003
2014
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
Toward the potential cure of leukemias in the next decade
2018
Chimeric Antigen Receptor Therapy
2018 Standout
Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells
2005
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies
2015
Asparagine Synthetase Chemotherapy
2006
Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance
2010
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
2013
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Regulation and cellular functions of class II phosphoinositide 3-kinases
2012
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
The biology of CML blast crisis
2004
The TCF-1 and LEF-1 Transcription Factors Have Cooperative and Opposing Roles in T Cell Development and Malignancy
2012
Works of Deqing Pei being referenced
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
2012
Agrobacterium tumefaciens -Mediated Transformation of Maize Embryos Using a Standard Binary Vector System
2002
Outcomes of Children With BCR-ABL1 –Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease
2014
The SWI/SNF Chromatin-Remodeling Complex and Glucocorticoid Resistance in Acute Lymphoblastic Leukemia
2008
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
2009
Statistical Significance Threshold Criteria For Analysis of Microarray Gene Expression Data
2004
Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment
2004
Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells
2011
High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia
2011
Inherited NUDT15 Variant Is a Genetic Determinant of Mercaptopurine Intolerance in Children With Acute Lymphoblastic Leukemia
2015
Ancestry and pharmacogenetics of antileukemic drug toxicity
2007
A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia
2007
Risk of Adverse Events After Completion of Therapy for Childhood Acute Lymphoblastic Leukemia
2005
Arf induces p53-dependent and -independent antiproliferative genes.
2003
Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2
2006
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital
2004